172 related articles for article (PubMed ID: 38033459)
1. Oral cannabidiol (CBD) as add-on to paracetamol for painful chronic osteoarthritis of the knee: a randomized, double-blind, placebo-controlled clinical trial.
Pramhas S; Thalhammer T; Terner S; Pickelsberger D; Gleiss A; Sator S; Kress HG
Lancet Reg Health Eur; 2023 Dec; 35():100777. PubMed ID: 38033459
[TBL] [Abstract][Full Text] [Related]
2. Don't Fear the Reefer-Evidence Mounts for Plant-Based Cannabidiol as Treatment for Epilepsy.
Perry MS
Epilepsy Curr; 2019; 19(2):93-95. PubMed ID: 30955420
[TBL] [Abstract][Full Text] [Related]
3. Paracetamol versus placebo for knee and hip osteoarthritis.
Leopoldino AO; Machado GC; Ferreira PH; Pinheiro MB; Day R; McLachlan AJ; Hunter DJ; Ferreira ML
Cochrane Database Syst Rev; 2019 Feb; 2(2):CD013273. PubMed ID: 30801133
[TBL] [Abstract][Full Text] [Related]
4. Effect of Tanezumab on Joint Pain, Physical Function, and Patient Global Assessment of Osteoarthritis Among Patients With Osteoarthritis of the Hip or Knee: A Randomized Clinical Trial.
Schnitzer TJ; Easton R; Pang S; Levinson DJ; Pixton G; Viktrup L; Davignon I; Brown MT; West CR; Verburg KM
JAMA; 2019 Jul; 322(1):37-48. PubMed ID: 31265100
[TBL] [Abstract][Full Text] [Related]
5. Tropomyosin-related kinase A (TrkA) inhibition for the treatment of painful knee osteoarthritis: results from a randomized controlled phase 2a trial.
Watt FE; Blauwet MB; Fakhoury A; Jacobs H; Smulders R; Lane NE
Osteoarthritis Cartilage; 2019 Nov; 27(11):1590-1598. PubMed ID: 31356878
[TBL] [Abstract][Full Text] [Related]
6. Chondroitin for osteoarthritis.
Singh JA; Noorbaloochi S; MacDonald R; Maxwell LJ
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD005614. PubMed ID: 25629804
[TBL] [Abstract][Full Text] [Related]
7. Effect of Vitamin D Supplementation on Tibial Cartilage Volume and Knee Pain Among Patients With Symptomatic Knee Osteoarthritis: A Randomized Clinical Trial.
Jin X; Jones G; Cicuttini F; Wluka A; Zhu Z; Han W; Antony B; Wang X; Winzenberg T; Blizzard L; Ding C
JAMA; 2016 Mar; 315(10):1005-13. PubMed ID: 26954409
[TBL] [Abstract][Full Text] [Related]
8. Nonsteroidal Anti-inflammatory Drugs vs Cognitive Behavioral Therapy for Arthritis Pain: A Randomized Withdrawal Trial.
Fraenkel L; Buta E; Suter L; Dubreuil M; Levy C; Najem C; Brennan M; Corn B; Kerns R; Goulet J
JAMA Intern Med; 2020 Sep; 180(9):1194-1202. PubMed ID: 32702101
[TBL] [Abstract][Full Text] [Related]
9. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
Kivitz A; Ma C; Ahdieh H; Galer BS
Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
[TBL] [Abstract][Full Text] [Related]
10. A randomized double-blind placebo-controlled trial to investigate the effectiveness and safety of a novel green-lipped mussel extract -BioLex® -for managing pain in moderate to severe osteoarthritis of the hip and knee.
Stebbings S; Gray A; Schneiders AG; Sansom A
BMC Complement Altern Med; 2017 Aug; 17(1):416. PubMed ID: 28830491
[TBL] [Abstract][Full Text] [Related]
11. A randomized study to evaluate the analgesic efficacy of a single dose of the TRPV1 antagonist mavatrep in patients with osteoarthritis.
Mayorga AJ; Flores CM; Trudeau JJ; Moyer JA; Shalayda K; Dale M; Frustaci ME; Katz N; Manitpisitkul P; Treister R; Ratcliffe S; Romano G
Scand J Pain; 2017 Oct; 17():134-143. PubMed ID: 28850367
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of twice daily sustained-release paracetamol formulation for osteoarthritis pain of the knee or hip: a randomized, double-blind, placebo-controlled, twelve-week study.
Reed K; Collaku A; Moreira S
Curr Med Res Opin; 2018 Apr; 34(4):689-699. PubMed ID: 29239664
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effect of Duhuo Jisheng Decoction add-on Tui-na manipulation on osteoarthritis of knee: a randomized controlled trial.
Chan KH; Ching JYL; Chan KL; Lau HY; Chu KM; Chan K; Pang HF; Wong LC; Chia CP; Zhang HW; Song T; Leung SB; Ng BFL; Lin ZX
Chin Med; 2023 Jul; 18(1):82. PubMed ID: 37424023
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of low-dose submicron diclofenac for the treatment of osteoarthritis pain: a 12 week, phase 3 study.
Gibofsky A; Hochberg MC; Jaros MJ; Young CL
Curr Med Res Opin; 2014 Sep; 30(9):1883-93. PubMed ID: 25050589
[TBL] [Abstract][Full Text] [Related]
15. Combined Treatment With Chondroitin Sulfate and Glucosamine Sulfate Shows No Superiority Over Placebo for Reduction of Joint Pain and Functional Impairment in Patients With Knee Osteoarthritis: A Six-Month Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Roman-Blas JA; Castañeda S; Sánchez-Pernaute O; Largo R; Herrero-Beaumont G;
Arthritis Rheumatol; 2017 Jan; 69(1):77-85. PubMed ID: 27477804
[TBL] [Abstract][Full Text] [Related]
16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
17. Nortriptyline for pain in knee osteoarthritis: a double-blind randomised controlled trial in New Zealand general practice.
Hudson B; Williman JA; Stamp LK; Alchin JS; Hooper GJ; Mangin D; Thompson BFL; Toop L
Br J Gen Pract; 2021 Jul; 71(708):e538-e546. PubMed ID: 33571950
[TBL] [Abstract][Full Text] [Related]
18. A 6-months, randomised, placebo-controlled evaluation of efficacy and tolerability of a low-dose 7-day buprenorphine transdermal patch in osteoarthritis patients naïve to potent opioids.
Breivik H; Ljosaa TM; Stengaard-Pedersen K; Persson J; Aro H; Villumsen J; Tvinnemose D
Scand J Pain; 2010 Jul; 1(3):122-141. PubMed ID: 29913983
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of topical diclofenac sodium gel for knee osteoarthritis in elderly and younger patients: pooled data from three randomized, double-blind, parallel-group, placebo-controlled, multicentre trials.
Baraf HS; Gloth FM; Barthel HR; Gold MS; Altman RD
Drugs Aging; 2011 Jan; 28(1):27-40. PubMed ID: 21174485
[TBL] [Abstract][Full Text] [Related]
20. Dose-Ranging Effect of Adjunctive Oral Cannabidiol vs Placebo on Convulsive Seizure Frequency in Dravet Syndrome: A Randomized Clinical Trial.
Miller I; Scheffer IE; Gunning B; Sanchez-Carpintero R; Gil-Nagel A; Perry MS; Saneto RP; Checketts D; Dunayevich E; Knappertz V;
JAMA Neurol; 2020 May; 77(5):613-621. PubMed ID: 32119035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
